microdosing glp-1 agonists Medications There isn't enough data to

GLP-1R agonist 2 has the potential for research in metabolic diseases such as type 2 diabetes and obesity

Read more about the new GLP-1 pill that outperformed oral semaglutide in a recent Phase III trial.

Provider oversight and coaching included.

Learn how retatrutide, a triplereceptor weightloss drug in clinical trials, works on GLP1, GIP, and glucagonand what early research shows.

Learn how different GLP-1 medications work, how they differ for weight loss vs diabetes and why dual agonists like tirzepatide stand out.

About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern, a new KFF Health Tracking Poll finds.